Combining Evidence and Patient Communication for Better Outcomes in OAB

Saturday, May 14, 2022

7:30 AM – 9:30 AM

Location: Room 265-268

Faculty(s)

Una Jeanie Lee, MD (she/her/hers)

Section Head, Section of Urology and Renal Transplantation
Virginia Mason Medical Center
Roger Roman Dmochowski, MD

Professor
Vanderbilt University Medical Center
Ekene Enemchukwu, MD (she/her/hers)

Associate Professor
Stanford University School of Medicine

Learning Objectives:

Review the data on central nervous system effects of antimuscarinic overactive bladder medications and β3-adrenoceptor agonists.
Apply communication strategies on managing overactive bladder to improve the patient-clinician partnership.
Review clinical trial data on new treatments for overactive bladder.
Develop appropriate treatment strategies for patients with overactive bladder.

Registration / Breakfast: 7:30 – 8am
Symposium: 8 – 9:30 am

TARGET AUDIENCE
This educational activity is intended for urologists, urogynecologists, physician assistants, nurse practitioners, nurses, and other clinicians involved in the care of patients with overactive bladder.

FOR PHYSICIANS
ACCME Accreditation Statement
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Credit Designation Statement
MedEdicus LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FOR NURSES
Interprofessional Joint Accreditation Statement
n support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.5 ANCC contact hours.

DISCLOSURE POLICY
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.

AMERICANS WITH DISABILITIES ACT
MedEdicus fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please contact info@mededicus.com with any special needs (eg, physical, dietary) prior to the program.

This continuing medical education activity is provided by MedEdicus LLC in collaboration with Amedco LLC.

This continuing medical education activity is supported through an educational grant from Urovant Sciences, Inc.

* Onsite seating is available until capacity is reached. Preregistered attendees will be seated first.

REGISTER NOW AT WWW.CMEOAB.COM